Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker – 4.2)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Open Access
Clockss

Download whole issue [PDF]

Contents – 2024, Vol. 33, No. 11 (November)

1

Editorial

Bioavailability of ursolic/oleanolic acid, with therapeutic potential in chronic diseases and cancer

1173-1178

2

Meta-analysis

Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer’s disease: A systematic review and meta-analysis

1179-1187

3

Original Article

Depressive disorders in children with chronic kidney disease treated conservatively

1189-1199

4

Original Article

Comparison of different treatment regimens and analysis of prognostic factors in secondary hemophagocytic lymphohistiocytosis in adults: A single-center retrospective study

1201-1208

5

Original Article

Study on regulating AQP1, AQP3, AQP4, 5-HT, NOS1 in slow transit constipation rats by Liqi Tongbian mixture

1209-1215

6

Original Article

BVES-AS1 suppresses the colorectal cancer progression via the miR-1269a/b-SVEP1-PI3K/AKT axis

1217-1236

7

Original Article

Parthenolide induces ROS-dependent cell death in human gastric cancer cell

1237-1245

8

Review

B10 cells: Development, phenotype, and function in cancer

1247-1258

9

Review

Metabolic encephalopathies in children: A pragmatic diagnostic approach based on literature analysis

1259-1265

10

Review

CBCT and modern intraoral scanners as tools for developing comprehensive, interdisciplinary treatment plans

1267-1276

11

Review

Current role of intravascular imaging in percutaneous treatment of calcified coronary lesions

1277-1287